Company Overview - Eagle Pharmaceuticals, Inc. is a fully integrated pharmaceutical company with expertise in research and development, clinical, manufacturing, and commercial sectors [2] - The company is dedicated to developing innovative medicines that significantly improve patients' lives [2] Product Portfolio - Eagle's commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), BYFAVO®, and BARHEMSYS® through its subsidiary Acacia Pharma Inc. [2] - The company has a pipeline focused on oncology and CNS/metabolic critical care, targeting underserved therapeutic areas across multiple disease states [2] Strategic Focus - Eagle is committed to developing medicines that have the potential to be integrated into the personalized medicine paradigm in cancer care [2]
Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements